Loring Wolcott & Coolidge Fiduciary Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $34.6K | Hold |
|
|||||
|
2025
Q2 | $29.2K | Hold |
|
|||||
|
2025
Q1 | $28.1K | Hold |
|
|||||
|
2024
Q4 | $27K | Hold |
|
|||||
|
2024
Q3 | $28.7K | Sell |
|
|||||
|
2024
Q2 | $84.8K | Hold |
|
|||||
|
2024
Q1 | $88.5K | Sell |
|
|||||
|
2023
Q4 | $95K | Hold |
|
|||||
|
2023
Q3 | $82.3K | Sell |
|
|||||
|
2023
Q2 | $250K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $231K | Hold |
|
|||||
|
2022
Q2 | $428K | Hold |
|
|||||
|
2022
Q1 | $428K | Sell |
|
|||||
|
2021
Q4 | $1.05M | Buy |
|
|||||
|
2021
Q3 | $752K | Sell |
|
|||||
|
2021
Q2 | $904K | Sell |
|
|||||
|
2021
Q1 | $979K | Sell |
|
|||||
|
2020
Q4 | $1.32M | Buy |
|
|||||
|
2020
Q3 | $1.35M | Buy |
|
|||||
|
2020
Q2 | $39K | Hold |
|
|||||
|
2020
Q1 | $36K | Hold |
|
|||||
|
2019
Q4 | $45K | Hold |
|
|||||
|
2019
Q3 | $41K | Hold |
|
|||||
|
2019
Q2 | $38K | Sell |
|
|||||
|
2019
Q1 | $50K | Hold |
|
|||||
|
2018
Q4 | $46K | Hold |
|
|||||
|
2018
Q3 | $48K | Sell |
|
|||||
|
2018
Q2 | $58K | Hold |
|
|||||
|
2018
Q1 | $57K | Hold |
|
|||||
|
2017
Q4 | $51K | Hold |
|
|||||
|
2017
Q3 | $59K | Sell |
|
|||||
|
2017
Q2 | $137K | Buy |
|
|||||
|
2017
Q1 | $140K | Sell |
|
|||||
|
2016
Q4 | $137K | Hold |
|
|||||
|
2016
Q3 | $153K | Sell |
|
|||||
|
2016
Q2 | $155K | Sell |
|
|||||
|
2016
Q1 | $147K | Hold |
|
|||||
|
2015
Q4 | $146K | Sell |
|
|||||
|
2015
Q3 | $172K | Hold |
|
|||||
|
2015
Q2 | $172K | Sell |
|
|||||
|
2015
Q1 | $202K | Hold |
|
|||||
|
2014
Q4 | $187K | Sell |
|
|||||
|
2014
Q3 | $224K | Hold |
|
|||||
|
2014
Q2 | $261K | Buy |
|
|||||
|
2014
Q1 | $253K | Sell |
|
|||||
|
2013
Q4 | $262K | Sell |
|
|||||
|
2013
Q3 | $252K | Sell |
|
|||||
|
2013
Q2 | $307K | Buy |
|